Noopept

Noopept is a Russian-developed synthetic dipeptide nootropic (GVS-111) with 1,000x greater potency than piracetam. It increases NGF and BDNF expression in hippocampus at 10-30mg/day (vs piracetam's 1,200-4,800mg). One Russian RCT showed improved cognitive function in post-stroke patients. NOT a dietary supplement — it's a synthetic pharmaceutical compound. Regulatory status varies by country (OTC in Russia, unapproved in US/EU). Limited Western clinical data. Dose: 10-30mg/day sublingual. --- *Reviewed by the Dose AI Research Team and Clinical Advisory Board* *Last updated: 2026-04-06*